Defense Secretary Pete Hegseth on Wednesday announced that all male service members aged 30 and older will undergo mandatory annual testosterone screening, with hormone replacement therapy available to those found deficient. The program, which Hegseth dubbed "The High-T Department of War" in a video posted to his official X account, marks the latest in a string of personnel and readiness directives from a Pentagon chief who has shown no interest in managing by committee.
Hegseth framed the initiative not as performance enhancement but as basic medical care, restoring what age takes away from the men who fight. Service members under 30 may volunteer for screening but will not be required to participate, Just The News reported. Any treatment, including testosterone replacement therapy, remains optional for those who screen positive.
The directive folds testosterone testing into existing periodic health assessments, meaning no new appointment cycle for troops already navigating the military's medical bureaucracy. What it does add is a formal diagnostic step the Pentagon has never required at scale, and a willingness to treat a condition the military has historically ignored or treated as a personal matter.
Hegseth's case: the warfighter as the military's best weapon
In the video announcement, Hegseth made a simple argument: the Defense Department spends billions on platforms, weapons systems, and gear, but the individual soldier remains the decisive advantage. As Newsmax reported, Hegseth tied the screening program directly to combat readiness and long-term health.
"While we invest heavily in our weapon systems, platforms and gear, our most decisive tactical advantage will always be the individual warfighter."
He went further, calling the effort a matter of obligation rather than preference. Hegseth told troops the Pentagon has "a sacred duty" to maintain the warfighter's edge, and that the testosterone program delivers on that duty by addressing a well-documented biological reality: testosterone levels decline with age, dragging down muscle mass, energy, mental sharpness, and resilience.
"This initiative, it's not about artificial enhancement; it's about restoring and optimizing your natural capabilities, protecting your longevity, ensuring you have the biological foundation required to sustain and fight."
The framing is deliberate. Hegseth drew a clear line between restoring natural hormone levels and the kind of artificial enhancement that has dogged elite military units in recent years.
A problem the Pentagon already knows about
The announcement does not arrive in a vacuum. Over the past several years, special operations troops, Navy SEALs in particular, have come under scrutiny for unsupervised use of testosterone and similar substances to maintain peak performance. In 2022, a SEAL recruit died during training, and substances including testosterone were found in his possession. That death revealed what investigators described as far more rampant drug use among the elite program than had been previously acknowledged.
The difference between that episode and Hegseth's new program is supervision. Unsanctioned hormone use by operators trying to keep up with brutal training cycles is a safety problem. A medically administered screening and treatment protocol run through the military health system is an answer to that problem, or at least an attempt at one.
This initiative fits a pattern. Hegseth has moved aggressively to reshape the Pentagon's approach to personnel standards, from forcing out senior commanders in Europe to tightening grooming and fitness requirements across the services.
The Washington Examiner noted that the testosterone screening sits alongside Hegseth's enforcement of strict no-beard policies, higher physical fitness benchmarks, and grooming compliance rules, all part of a broader push to restore a culture of physical readiness that critics say had drifted during the previous administration's focus on diversity and inclusion programming.
The numbers behind the policy
Roughly 5.6 percent of men between ages 30 and 79 have testosterone deficiency, Breitbart reported, citing established medical data. The condition can cause muscle loss, fatigue, weight gain, sexual dysfunction, and a range of other health issues that directly undermine a service member's ability to perform.
The scale of related health problems within the ranks is hard to ignore. A record 108,332 erectile dysfunction prescriptions were issued to active military personnel in 2025, up slightly from 108,323 the year before, the New York Post reported. Those numbers suggest a force dealing with hormonal and physiological decline that the existing medical system has been treating symptom by symptom rather than at the root.
Hegseth's directive tries to get upstream of the problem. Screen early, diagnose accurately, treat voluntarily. Whether the military medical infrastructure can absorb the added diagnostic load across all branches, the program's scope has not been limited to specific units, remains an open question.
The Army has already been moving in the direction of tougher physical standards. Its new Combat Field Test for frontline troops reflects the same institutional bet: that readiness starts with the body, and that the services had let standards slip.
Broader administration alignment
Hegseth is not operating alone on this front. The testosterone screening program aligns with a wider Trump administration push to expand access to hormone replacement therapy for men. The FDA has proposed easing prescribing limits on testosterone treatments, and Robert F. Kennedy Jr. has advocated for broader testosterone access as part of his public health agenda, the Associated Press reported.
That alignment will draw criticism. Sen. Tammy Duckworth, an Iraq War veteran, compared the testosterone program to "gender-affirming care," a jab aimed at Hegseth's well-publicized opposition to transgender service members. The comparison is a stretch, treating a diagnosed hormone deficiency in biological males is not the same as cross-sex hormone therapy, but it signals the political lane Democrats intend to occupy.
Hegseth's response, built into the announcement itself, anticipated that line of attack. He emphasized repeatedly that the program addresses natural decline, not artificial enhancement, and that participation in any treatment is voluntary.
The Pentagon has not cited specific research supporting the initiative beyond the general medical consensus on age-related testosterone decline, the AP noted. That gap will give skeptics room to argue the program is more cultural signal than clinical necessity. But the medical literature on testosterone deficiency is not thin, and the military's own prescription data suggests the problem is real and growing.
What remains unanswered
Several practical questions remain. Hegseth "authorized" the program, but the formal legal mechanism, whether a directive, memorandum, or executive order, has not been specified. The funding source and the medical infrastructure that will administer hundreds of thousands of additional blood tests annually have not been detailed.
Hegseth has shown a willingness to move fast and sort out institutional resistance later. He ended the mandatory flu vaccine for troops earlier this year, citing medical autonomy, a decision that drew similar questions about process and implementation.
Whether the testosterone program applies equally across all branches or will roll out in phases is also unclear. The announcement made no distinction between combat arms, support units, or reserve components. For a force that spans millions of service members, the logistics matter as much as the policy intent.
That said, the political dynamics around Hegseth's leadership are not simple. Even some Republicans have pushed back on aspects of his management style, as seen in recent Senate moves to cut his travel budget over transparency concerns. The testosterone initiative may prove easier to defend on the merits than some of his personnel decisions.
Readiness over politics
Hegseth closed his announcement with a line that cut through the noise.
"We owe our warriors the absolute best medical care in the world. And this program delivers on that obligation."
Strip away the branding, "The High-T Department of War" is not subtle, and the core proposition is straightforward. The military has known for years that its troops are aging, that hormone decline affects performance, and that unsupervised self-treatment in elite units has led to at least one death. Hegseth's answer is to bring the issue into the open, screen for it systematically, and offer treatment under medical supervision.
Critics will call it a culture-war stunt. But the troops dealing with fatigue, muscle loss, and declining readiness at 35 are not engaged in a culture war. They are trying to stay fit enough to fight. A Pentagon that spent years prioritizing pronoun policies over physical standards is in no position to lecture anyone about misplaced priorities.
If the program works, it keeps warfighters in the fight longer. If it doesn't, it was voluntary anyway. The real question is why it took this long for anyone at the Pentagon to treat the problem like a medical issue instead of pretending it didn't exist.
